Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$173,344,988
+$10,002,087 QoQ
Shares Held
1,518,705
-7.3% QoQ
Ownership
3.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 12.68738826829437.ToString("F0")%
Shared 0.ToString("F0")%
None 87.31261173170563.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. CELC ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in CELC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $173,344,988 | 1,518,705 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $163,342,901 | 1,637,687 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $35,706,320 | 722,800 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,841,843 | 587,404 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,916,169 | 585,180 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,516,477 | 879,792 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,511,557 | 1,107,415 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,192,408 | 439,097 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,269,264 | 336,540 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,322,292 | 296,657 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,517,375 | 275,424 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,875,662 | 261,900 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $321,645 | 31,380 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $439,633 | 31,380 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $315,055 | 31,380 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $285,558 | 31,380 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,391,298 | 148,802 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,903,791 | 144,336 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,489,112 | 138,284 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,101,976 | 129,249 | Shares | Defined | 2021-08-16 | |
| 2020-03-31 | $582,770 | 89,657 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||